labetalol has been researched along with atropine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Sommers, DK | 1 |
| Dundee, JW; Morrow, WF | 1 |
| Apud, JA; Monasterolo, L | 1 |
| Bi, K; Idid, SZ; Mahmud, Z; Merican, Z; Morat, P | 1 |
| Bory, M; Dayan-Benattar, N; Djiane, P; Sainsous, J; Serradimigni, A | 1 |
| Germond, C; Kallenbach, J; Lewis, M; Muller, F; Steyn, J; Zaltzman, M; Zwi, S | 1 |
| Huddart, H; King, JA; Staff, WG | 1 |
| Brocher, N; Copeland, A; Godfrey, J; Thornton, H; Wilson, C | 1 |
| Chen, CY; Chen, JF; Day, YJ; Hsu, YC; Luo, CF | 1 |
| Chen, B; Chu, C; Fang, L; Lin, T; Tong, S; Xu, P; You, H | 1 |
1 review(s) available for labetalol and atropine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
24 other study(ies) available for labetalol and atropine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Reactivity of the cardiovascular system in the tetraplegic patient.
Topics: Adrenergic beta-Antagonists; Atropine; Blood Pressure; Electrocardiography; Guanethidine; Heart Rate; Hemodynamics; Humans; Labetalol; Male; Nitroglycerin; Phenoxybenzamine; Posture; Propranolol; Quadriplegia; Sympathetic Nervous System; Systole | 1979 |
Labetalol in severe tetanus.
Topics: Adult; Atropine; Ethanolamines; Humans; Infusions, Parenteral; Labetalol; Male; Tetanus | 1979 |
Acetylcholine modulates the effect of ovarian steroids on glutamic acid decarboxylase activity in the rat fallopian tube.
Topics: Acetylcholine; alpha-Methyltyrosine; Animals; Atropine; Benzoates; Estradiol; Fallopian Tubes; Female; Glutamate Decarboxylase; Labetalol; Methyltyrosines; Neostigmine; Ovariectomy; Ovary; Progesterone; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Steroids | 1991 |
The effects of simultaneous atropine and labetalol administration on cardiovascular parameters during anticholinesterase poisoning in anaesthetized cat.
Topics: Animals; Atropine; Cats; Cholinesterase Inhibitors; Drug Therapy, Combination; Female; Hemodynamics; Labetalol; Male; Neostigmine | 1987 |
[Chemical blockade of the cardiac autonomic nervous system. Effects on the coronary arterial vasomotor activity].
Topics: Adult; Aged; Atropine; Autonomic Nerve Block; Blood Pressure; Coronary Vasospasm; Drug Therapy, Combination; Electrocardiography; Ethanolamines; Female; Heart; Heart Rate; Humans; Labetalol; Male; Middle Aged; Radionuclide Imaging | 1985 |
Survival following massive overdose of adrenergic blocking agents (acebutolol and labetalol).
Topics: Acebutolol; Adult; Atropine; Blood Pressure; Dopamine; Ethanolamines; Female; Heart Rate; Hemodynamics; Humans; Isoproterenol; Labetalol; Suicide, Attempted; Trimipramine | 1983 |
Purinergic modulation of rat urinary bladder detrusor smooth muscle.
Topics: Adenosine; Adenosine Triphosphate; Animals; Atropine; Caffeine; Electric Stimulation; In Vitro Techniques; Labetalol; Male; Muscle, Smooth; Purinergic Agonists; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Quinidine; Rats; Rats, Wistar; Receptors, Purinergic; Urinary Bladder | 1997 |
The effects of atropine and adrenergic antagonists on behavioral arousal in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arousal; Atropine; Drug Synergism; Labetalol; Motor Activity; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley | 2000 |
Comparison of the effects of atropine and labetalol on trigeminocardiac reflex-induced hemodynamic alterations during percutaneous microballoon compression of the trigeminal ganglion.
Topics: Adult; Aged; Atropine; Female; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Prospective Studies; Reflex, Trigeminocardiac; Trigeminal Ganglion; Trigeminal Neuralgia | 2012 |
Enantioseparation of five racemic N-alkyl drugs by reverse phase HPLC using sulfobutylether-β-cyclodextrin as a chiral mobile phase additive.
Topics: Atropine; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Fluoxetine; Indicators and Reagents; Labetalol; Stereoisomerism; Venlafaxine Hydrochloride | 2022 |